Research ArticleArticle
Open Access
Molecular and Functional Characterization of GABA Receptor Subunits GRD and LCCH3 from Human Louse Pediculus Humanus Humanus
Omar Hashim, Claude L. Charvet, Berthine Toubaté, Aimun A.E. Ahmed, Nicolas Lamassiaude, Cédric Neveu, Isabelle Dimier-Poisson, Françoise Debierre-Grockiego and Catherine Dupuy
Molecular Pharmacology August 2022, 102 (2) 116-127; DOI: https://doi.org/10.1124/molpharm.122.000499
Omar Hashim
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Claude L. Charvet
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Berthine Toubaté
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Aimun A.E. Ahmed
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Nicolas Lamassiaude
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Cédric Neveu
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Isabelle Dimier-Poisson
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Françoise Debierre-Grockiego
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)
Catherine Dupuy
INRAE, Université de Tours, ISP, BioMAP, 37200, Tours, France (O.H., B.T., I.D.-P., F.D.-G., C.D.); Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan (O.H.); INRAE, Université de Tours, ISP, MPN, 37380, Nouzilly, France (C.L.C., N.L., C.N.); Department of Pharmacology, Albaha University, Alaqiq, Saudi Arabia (A.A.E.A.); and Department of Pharmacology and Toxicology, Omdurman Islamic University, Omdurman, Sudan (A.A.E.A.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Characterization of GRD and LCCH3 from Human Louse
Omar Hashim, Claude L. Charvet, Berthine Toubaté, Aimun A.E. Ahmed, Nicolas Lamassiaude, Cédric Neveu, Isabelle Dimier-Poisson, Françoise Debierre-Grockiego and Catherine Dupuy
Molecular Pharmacology August 1, 2022, 102 (2) 116-127; DOI: https://doi.org/10.1124/molpharm.122.000499
Research ArticleArticle
Characterization of GRD and LCCH3 from Human Louse
Omar Hashim, Claude L. Charvet, Berthine Toubaté, Aimun A.E. Ahmed, Nicolas Lamassiaude, Cédric Neveu, Isabelle Dimier-Poisson, Françoise Debierre-Grockiego and Catherine Dupuy
Molecular Pharmacology August 1, 2022, 102 (2) 116-127; DOI: https://doi.org/10.1124/molpharm.122.000499
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement